Published On: Thursday, July 8, 2021 | By: Team KnowMyStock
Anil Jain, Joint Managing Director, Bajaj Healthcare said "We are pleased to add 2-Deoxy-D-Glucose to our growing product portfolios after receiving the license from DRDO. Our countries medical infrastructure is really struggling with the scarcity of oxygen capacities. We hope the availability of an effective treatment such as 2-DG will considerably ease the pressure and offer patients much-needed and timely therapy options. Most patients ailing from moderate to severe symptoms can benefit from its use."
Follow Us On: